XPH
State Street SPDR S&P Pharmaceuticals ETFstockNYSEETF
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 67.02 | 2026-11-12 | -4.07% | 1.403 |
| 1M | 62.24 | 2026-10-19 | +3.29% | 1.133 |
| 3M | 74.06 | 2026-08-19 | -13.19% | 1.014 |
| 6M | 55.81 | 2026-05-19 | +15.19% | 0.689 |
| 1Y | 52.17 | 2025-11-19 | +23.23% | 0.866 |
| 2Y | 45.24 | 2024-11-19 | +42.11% | — |
| 5Y | 48.13 | 2021-11-19 | +33.58% | 0.769 |
State Street SPDR S&P Pharmaceuticals ETF (NYSE:XPH) stock price today is $64.29, and today's volume is 258,271. XPH is up 0.203% today. The 30 day average volume is 193,404. XPH market cap is $495.05M with 7.70M shares outstanding.